Leukocyte Proliferation and Immune Modulator Production in Patients with Chronic Kidney Disease

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Mansouri, Ladan ^a   Paulsson, Josefin M ^a   Moshfegh, Ali ^a   Jacobson, Stefan H ^b   Lundahl, Joachim ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; CONCANAVALIN A; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOMODULATING AGENT; INFLUENZA VACCINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LYMPHOTOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MITOGENIC AGENT; MONOCYTE CHEMOTACTIC PROTEIN 1; STAPHYLOCOCCUS ENTEROTOXIN A; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRIC ASSAY OF SPECIFIC CELL MEDIATED IMMUNE RESPONSE IN ACTIVATED WHOLE BLOOD; GLOMERULUS FILTRATION RATE; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOBLAST; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL LYMPHOCYTE; SUPERNATANT;

EID: 84881251519     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073141     Document Type: Article

References (37)

1. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, et al. (2006) Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 17: 2034-2047. doi:10.1681/ASN.2005101085. PubMed: 16738019.
2. Sarnak MJ, Jaber BL, (2000) Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 58: 1758-1764. doi:10.1111/j.1523-1755.2000.00337.x. PubMed: 11012910.
3. Vaziri ND, Pahl MV, Crum A, Norris K, (2012) Effect of uremia on structure and function of immune system. J Ren Nutr 22: 149-156. doi:10.1053/j.jrn.2011.10.020. PubMed: 22200433.
4. Ando M, Shibuya A, Yasuda M, Azuma N, Tsuchiya K, et al. (2005) Impairment of innate cellular response to in vitro stimuli in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 20: 2497-2503. doi:10.1093/ndt/gfi048. PubMed: 16077138.
5. Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, et al. (2008) Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 3: 1526-1533. doi:10.2215/CJN.00950208. PubMed: 18701615.
6. Banche G, Allizond V, Giacchino F, Mandras N, Roana J, et al. (2006) Effect of dialysis membrane biocompatibility on polymorphonuclear granulocyte activity in dialysis patients. Nephrol Dial Transplant 21: 3532-3538. doi:10.1093/ndt/gfl415. PubMed: 16935897.
7. Lim WH, Kireta S, Leedham E, Russ GR, Coates PT, (2007) Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients. Kidney Int 72: 1138-1148. doi:10.1038/sj.ki.5002425. PubMed: 17728708.
8. Fernández-Fresnedo G, Ramos MA, González-Pardo MC, de Francisco AL, López-Hoyos M, et al. (2000) B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2. Nephrol Dial Transplant 15: 502-510. doi:10.1093/ndt/15.4.502. PubMed: 10727545.
9. Kimmel PL, Phillips TM, Phillips E, Bosch JP, (1990) Effect of renal replacement therapy on cellular cytokine production in patients with renal disease. Kidney Int 38: 129-135. doi:10.1038/ki.1990.177. PubMed: 2385082.
10. Ankersmit HJ, Deicher R, Moser B, Teufel I, Roth G, et al. (2001) Impaired T cell proliferation, increased soluble death-inducing receptors and activation-induced T cell death in patients undergoing haemodialysis. Clin Exp Immunol 125: 142-148. doi:10.1046/j.1365-2249.2001.01590.x. PubMed: 11472437.
11. van Riemsdijk IC, Baan CC, Loonen EH, Zietse R, Weimar W, (2003) Patients on chronic hemodialysis have no intrinsic lymphocyte defect upon stimulation with interleukin-2, interleukin-15 or tumor necrosis factor-alpha. Blood Purif 21: 158-162. doi:10.1159/000069154. PubMed: 12601258.
12. van Riemsdijk IC, Baan CC, Loonen EH, Knoop CJ, Navarro Betonico G, et al. (2001) T cells activate the tumor necrosis factor-alpha system during hemodialysis, resulting in tachyphylaxis. Kidney Int 59: 883-892. doi:10.1046/j.1523-1755.2001.059003883.x. PubMed: 11231343.
13. Lisowska KA, De{ogonek}bska-Ślizień A, Jasiulewicz A, Heleniak Z, Bryl E, et al. (2012) Hemodialysis affects phenotype and proliferation of CD4-positive T lymphocytes. J Clin Immunol 32: 189-200. doi:10.1007/s10875-011-9603-x. PubMed: 21993694.
14. Mookerjee BK, (1976) Influence of separation techniques on the distribution and function of lymphocyte subpopulations. A comparison of three techniques. Transplantation 22: 101-107. doi:10.1097/00007890-197608000-00004. PubMed: 968932.
15. Mallone R, Mannering SI, Brooks-Worrell BM, Durinovic-Belló I, Cilio CM, et al. (2011) Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society. Clin Exp Immunol 163: 33-49. doi:10.1111/j.1365-2249.2010.04272.x. PubMed: 20939860.
16. Gaines H, Andersson L, Biberfeld G, (1996) A new method for measuring lymphoproliferation at the single-cell level in whole blood cultures by flow cytometry. J Immunol Methods 195: 63-72. doi:10.1016/0022-1759(96)00085-3. PubMed: 8814321.
17. Svahn A, Linde A, Thorstensson R, Karlén K, Andersson L, et al. (2003) Development and evaluation of a flow-cytometric assay of specific cell-mediated immune response in activated whole blood for the detection of cell-mediated immunity against varicella-zoster virus. J Immunol Methods 277: 17-25. doi:10.1016/S0022-1759(03)00111-X. PubMed: 12799036.
18. Aboud S, Nilsson C, Karlén K, Marovich M, Wahren B, et al. (2010) Strong HIV-specific CD4+ and CD8+ T-lymphocyte proliferative responses in healthy individuals immunized with an HIV-1 DNA vaccine and boosted with recombinant modified vaccinia virus ankara expressing HIV-1 genes. Clin Vaccine Immunol 17: 1124-1131. doi:10.1128/CVI.00008-10. PubMed: 20463104.
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470. doi:10.7326/0003-4819-130-6-199903160-00002. PubMed: 10075613.
20. Ledebo I, (2007) Ultrapure dialysis fluid--how pure is it and do we need it? Nephrol Dial Transplant 22: 20-23. doi:10.1093/ndt/gfm294. PubMed: 17035373.
21. Borgström E, Andersen P, Andersson L, Julander I, Källenius G, et al. (2011) Detection of proliferative responses to ESAT-6 and CFP-10 by FASCIA assay for diagnosis of Mycobacterium tuberculosis infection. J Immunol Methods 370: 55-64. doi:10.1016/j.jim.2011.05.008. PubMed: 21641911.
22. Weil AA, Arifuzzaman M, Bhuiyan TR, LaRocque RC, Harris AM, et al. (2009) Memory T-cell responses to Vibrio cholerae O1 infection. Infect Immun 77: 5090-5096. doi:10.1128/IAI.00793-09. PubMed: 19703973.
23. Ahmed T, Arifuzzaman M, Lebens M, Qadri F, Lundgren A, (2009) CD4+ T-cell responses to an oral inactivated cholera vaccine in young children in a cholera endemic country and the enhancing effect of zinc supplementation. Vaccine 28: 422-429. doi:10.1016/j.vaccine.2009.10.032. PubMed: 19837094.
24. Deenadayalan A, Maddineni P, Raja A, (2013) Comparison of whole blood and PBMC assays for T-cell functional analysis. BMC Res Notes 6: 120. doi:10.1186/1756-0500-6-120. PubMed: 23531281.
25. Weir RE, Morgan AR, Britton WJ, Butlin CR, Dockrell HM, (1994) Development of a whole blood assay to measure T cell responses to leprosy: a new tool for immuno-epidemiological field studies of leprosy immunity. J Immunol Methods 176: 93-101. doi:10.1016/0022-1759(94)90353-0. PubMed: 7963598.
26. Stachowski J, Pollok M, Burrichter H, Spithaler C, Baldamus CA, (1993) Signalling via the TCR/CD3 antigen receptor complex in uremia is limited by the receptors number. Nephron 64: 369-375. doi:10.1159/000187356. PubMed: 8101978.
27. Lisowska KA, Debska-Slizien A, Radzka M, Witkowski JM, Rutkowski B, et al. (2010) Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes. Artif Organs 34: E77-E84. doi:10.1111/j.1525-1594.2009.00942.x. PubMed: 20447038.
28. Fliser D, Buchholz K, Haller H, Olmesartan EUTo, Pravastatin in I, et al. (2004) Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation 110: 1103-1107.
29. Platten M, Youssef S, Hur EM, Ho PP, Han MH, et al. (2009) Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc Natl Acad Sci U S A 106: 14948-14953. doi:10.1073/pnas.0903958106. PubMed: 19706421.
30. Ma A, Koka R, Burkett P, (2006) Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol 24: 657-679. doi:10.1146/annurev.immunol.24.021605.090727. PubMed: 16551262.
31. Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH, (1995) IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 154: 483-490. PubMed: 7814861.
32. Armitage RJ, Macduff BM, Spriggs MK, Fanslow WC, (1993) Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol 150: 3671-3680. PubMed: 8097223.
33. Jacobson SH, Thylén P, Lundahl J, (2000) Three monocyte-related determinants of atherosclerosis in haemodialysis. Nephrol Dial Transplant 15: 1414-1419. doi:10.1093/ndt/15.9.1414. PubMed: 10978400.
34. Rysz J, Banach M, Cialkowska-Rysz A, Stolarek R, Barylski M, et al. (2006) Blood serum levels of IL-2, IL-6, IL-8, TNF-alpha and IL-1beta in patients on maintenance hemodialysis. Cell Mol Immunol 3: 151-154. PubMed: 16696903.
35. Padovan E, Spagnoli GC, Ferrantini M, Heberer M, (2002) IFN-alpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells. J Leukoc Biol 71: 669-676. PubMed: 11927654.
36. Brunet P, Capo C, Dellacasagrande J, Thirion X, Mege JL, et al. (1998) IL-10 synthesis and secretion by peripheral blood mononuclear cells in haemodialysis patients. Nephrol Dial Transplant 13: 1745-1751. doi:10.1093/ndt/13.7.1745. PubMed: 9681722.
37. Jimenez R, Carracedo J, Santamaría R, Soriano S, Madueño JA, et al. (2005) Replicative senescence in patients with chronic kidney failure. Kidney Int Suppl: pp. S11-S15. PubMed: 16336562.